JP2024532851A5 - - Google Patents
Info
- Publication number
- JP2024532851A5 JP2024532851A5 JP2024510275A JP2024510275A JP2024532851A5 JP 2024532851 A5 JP2024532851 A5 JP 2024532851A5 JP 2024510275 A JP2024510275 A JP 2024510275A JP 2024510275 A JP2024510275 A JP 2024510275A JP 2024532851 A5 JP2024532851 A5 JP 2024532851A5
- Authority
- JP
- Japan
- Prior art keywords
- application
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234514P | 2021-08-18 | 2021-08-18 | |
| US63/234,514 | 2021-08-18 | ||
| PCT/US2022/075140 WO2023023596A1 (en) | 2021-08-18 | 2022-08-18 | Compositions and methods for chimeric antigen receptors specific to b cell receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532851A JP2024532851A (ja) | 2024-09-10 |
| JP2024532851A5 true JP2024532851A5 (https=) | 2025-08-26 |
Family
ID=85241066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510275A Pending JP2024532851A (ja) | 2021-08-18 | 2022-08-18 | Ｂ細胞受容体に特異的なキメラ抗原受容体のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240376197A1 (https=) |
| EP (1) | EP4387990A4 (https=) |
| JP (1) | JP2024532851A (https=) |
| KR (1) | KR20240112252A (https=) |
| CN (1) | CN118613499A (https=) |
| AU (1) | AU2022330127A1 (https=) |
| CA (1) | CA3229193A1 (https=) |
| IL (1) | IL310901A (https=) |
| MX (1) | MX2024002172A (https=) |
| WO (1) | WO2023023596A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112105641A (zh) * | 2018-03-19 | 2020-12-18 | 科塔生物治疗有限责任公司 | 用于经修饰的b细胞表达重新分配的生物剂的组合物和方法 |
| KR20260005221A (ko) * | 2023-03-09 | 2026-01-09 | 허밍버드 바이오사이언스 피티이. 엘티디. | Vh4-34 항원 결합 분자 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015524255A (ja) * | 2012-07-13 | 2015-08-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 二重特異性抗体を共導入することによってｃａｒｔ細胞の活性を強化する方法 |
| CA3035081A1 (en) * | 2016-09-02 | 2018-03-08 | Dana-Farber Cancer Institute, Inc. | Composition and methods of treating b cell disorders |
| EP3529268B1 (en) * | 2016-10-19 | 2025-02-26 | The Scripps Research Institute | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
| EP3424527A1 (de) * | 2017-07-07 | 2019-01-09 | AVA Lifescience GmbH | Diagnostisches verfahren |
| US20200085869A1 (en) * | 2018-05-16 | 2020-03-19 | Novartis Ag | Therapeutic regimens for chimeric antigen receptor therapies |
| CA3105816A1 (en) * | 2018-07-10 | 2020-01-16 | Precigen, Inc. | Ror-1 specific chimeric antigen receptors and uses thereof |
| IL281428B2 (en) * | 2018-09-27 | 2024-10-01 | Autolus Ltd | Chimeric antigen receptor |
| JP7748935B2 (ja) * | 2019-08-27 | 2025-10-03 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ＩＬ１３Ｒα２陽性ヒト腫瘍およびイヌ腫瘍を処置するための合成ＣＡＲ |
| EP4469067A1 (en) * | 2022-01-25 | 2024-12-04 | Ramot at Tel-Aviv University Ltd. | Engineering b cells to express chimeric antigen receptors (cars) and uses thereof for t cell independent activation |
| CA3262006A1 (en) * | 2022-07-25 | 2024-02-01 | Sinabiosolution Gmbh | Humanized chimeric antigen receptors targeting the B-lymphocyte receptor in chronic lymphocytic leukemia and their uses |
-
2022
- 2022-08-18 IL IL310901A patent/IL310901A/en unknown
- 2022-08-18 MX MX2024002172A patent/MX2024002172A/es unknown
- 2022-08-18 AU AU2022330127A patent/AU2022330127A1/en active Pending
- 2022-08-18 US US18/684,598 patent/US20240376197A1/en active Pending
- 2022-08-18 WO PCT/US2022/075140 patent/WO2023023596A1/en not_active Ceased
- 2022-08-18 JP JP2024510275A patent/JP2024532851A/ja active Pending
- 2022-08-18 CN CN202280069813.9A patent/CN118613499A/zh active Pending
- 2022-08-18 CA CA3229193A patent/CA3229193A1/en active Pending
- 2022-08-18 KR KR1020247008799A patent/KR20240112252A/ko active Pending
- 2022-08-18 EP EP22859384.4A patent/EP4387990A4/en active Pending